MiPLA

MiPLA
Clinical data
Other names	MiPLA; MIPLA; Lysergic acid methylisopropylamide; N-Methyl-N-isopropyllysergamide; LAMIDE; LA-Me/iso
Routes of; administration	Oral
Drug class	Serotonin receptor modulator; 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act; US: Schedule I (isomer of LSD); Illegal in France;
Pharmacokinetic data
Onset of action	20–40 minutes
Duration of action	4–6 hours
Identifiers
	IUPAC name (8β)-N-Isopropyl-N,6-dimethyl-9,10-didehydroergoline-8-carboxamide;
CAS Number	100768-08-9 ;
PubChem CID	57507938;
ChemSpider	128916995;
UNII	AC6WQQ5Y4B;
Chemical and physical data
Formula	C20H25N3O
Molar mass	323.440 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C4N(C)C1Cc2c[nH]c(ccc3)c2c3C1=CC4C(=O)N(C)C(C)C;
	InChI InChI=1S/C20H25N3O/c1-12(2)23(4)20(24)14-8-16-15-6-5-7-17-19(15)13(10-21-17)9-18(16)22(3)11-14/h5-8,10,12,14,18,21H,9,11H2,1-4H3; Key:ROICYBLUWUMJFF-UHFFFAOYSA-N;
	(verify)

MiPLA, also known as N-methyl-N-isopropyllysergamide or as lysergic acid methylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is taken orally. The drug is a structural isomer of LSD in which the N,N-diethyl groups have been replaced with N-methyl and N-isopropyl groups. It is only somewhat less potent than LSD as a psychedelic. MiPLA has been encountered as a novel designer drug.